Insights

Chinese consumers’ demand for healthier lifestyles has been increasing since the COVID-19 pandemic.

The Singaporean-based startup wants to reduce adverse drug reactions and increase prescription efficacy through pharmacogenetic testing.

Lalamove’s risk-taking founder has prioritized the firm’s expansion over basic safety fundamentals, critics say.

Outsourcing companies are more likely to experience the harsher parts of crunch culture.

The number of micro VC funds in the world’s third-largest startup ecosystem has increased to 88 in 2020 from 29 in 2014.

i-BrainTech is training athletes’ brains to boost their overall performance.

A handful of startups from tier 2 and 3 cities have raised money from funds like Sequoia Capital, CDC Group, Chiratae Ventures, and RTP Global.

Nazara will not raise fresh cash through the IPO, but the listing will raise the company’s profile globally and bring more investment opportunities in the future.